Feasibility of Teleyoga for Treatment of Lyme Disease
NCT04867473 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2024-03-08
Summary
Primary Aims: Modify an existing teleyoga intervention to use with Lyme disease (LD) patients and address the technical challenges of at-home teleyoga
Conditions
- Lyme Disease
Interventions
- BEHAVIORAL
-
Teleyoga
12 weekly 75 minute therapist-led teleyoga sessions
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Peter J Bayley, Ph.D. · VA Palo Alto Health Care System and Stanford University
-
Jerome A Yesavage, M.D. · Stanford University and VA Palo Alto Health Care System
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-01
- Primary Completion
- 2022-11-10
- Completion
- 2022-12-04
Countries
- United States
Study Locations
More Related Trials
-
Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis
NCT02553473 ·Status: COMPLETED ·Phase: PHASE3
-
Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes
NCT00958139 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation, Treatment, and Follow-up of Patients With Lyme Disease
NCT00028080 ·Status: RECRUITING
-
Tick-borne Illness and Clothing Study of Rhode Island
NCT02613585 ·Status: COMPLETED ·Phase: NA
-
PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics
NCT04577053 ·Status: TERMINATED ·Phase: NA
-
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
NCT00001539 ·Status: RECRUITING
-
Impact on the Quality of Life and Persistent Symptoms of Patients Away From Diagnosed and Treated Neuroborreliosis
NCT05742139 ·Status: COMPLETED
-
A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome
NCT04141969 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Direct Diagnosis of Disseminated Lyme Borreliosis.
NCT04719962 ·Status: UNKNOWN ·Phase: NA
-
Study and Treatment of Post Lyme Disease (STOP-LD)
NCT00000937 ·Status: COMPLETED ·Phase: PHASE3
-
Lyme Disease Prevention Program
NCT00000432 ·Status: COMPLETED ·Phase: PHASE3
-
Tick-borne Encephalitis Virus Research in Limousin
NCT05941546 ·Status: COMPLETED
-
Evaluation and Follow-up of People With Tick-borne Diseases
NCT04318925 ·Status: WITHDRAWN
-
Xenodiagnosis After Antibiotic Treatment for Lyme Disease
NCT02446626 ·Status: COMPLETED ·Phase: NA
-
Tick-borne Encephalitis and Positive Borrelial Antibodies
NCT02463942 ·Status: UNKNOWN ·Phase: NA
-
An Intervention in a Primary Healthcare Setting to Reduce Lyme Neuroborreliosis Treatment Delay
NCT03820999 ·Status: UNKNOWN ·Phase: NA
-
Understanding Tick-borne Diseases
NCT03501407 ·Status: UNKNOWN
-
Risk of Exposure and Prevention of Ticks and Tick-borne Diseases Among Foresters in Alsace
NCT06492668 ·Status: RECRUITING
-
Evolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and Meningoencephalitis
NCT07186881 ·Status: ENROLLING_BY_INVITATION
-
A Multicenter Study to Evaluate a Borrelia Diagnostic Test in Subjects With Early Stage or Late Stage Lyme Disease
NCT02741609 ·Status: TERMINATED ·Phase: NA
-
Human Immune Response to Ixodes Scapularis Tick Bites
NCT05036707 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease
NCT00000938 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease
NCT00001101 ·Status: COMPLETED ·Phase: PHASE3
-
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Lyme Disease
NCT04148222 ·Status: WITHDRAWN
-
A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
NCT05975099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2